跳至主要内容
临床试验/CTRI/2023/08/056655
CTRI/2023/08/056655已完成Unknown

Evaluation of dermatological safety and hypo allergenicity of investigational products by Human Repeat Insult Patch Test HRIPT on healthy human volunteers as per IS 4011:2018 - HRIPT

Sreedhareeyam Farmherbs India P Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Voluntary men/women between 18 and 65 years.
  • Photo type III to V.
  • Self-declaration of subject with sensitive skin.
  • Having apparently healthy skin on test area.
  • For whom the investigator considers that the compliance will be correct.
  • Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
  • Having signed a Consent Form.
  • Willingness to avoid intense UV exposure on test site (sun or artificial UV), during the course of the study.
  • Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna…), during the course of the study.
  • Should be able to read and write (in English, Hindi or local language).
  • Having valid proof of identity and age.

排除标准

  • Pregnant/nursing mothers
  • Scars, excessive terminal hair or tattoo on the studied area.
  • Henna tattoo anywhere on the body (in case of studies involving hair dyes).
  • Dermatological infection/pathology on the level of studied area.
  • Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye).
  • Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures.
  • Chronic illness which may influence the outcome of the study.
  • Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
  • Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.

研究者

发起方
Sreedhareeyam Farmherbs India P Ltd

相似试验